Pasithea TherapeuticsKTTA
13F holders, Q2 2026 (June 30)25holders +4
4new positions
0sold out
1famous investor
$0.52avg. 13F price*
At the end of Q2 2026, 25 institutions reported holding Pasithea Therapeutics Corp. (KTTA) in their 13F filings, up 4 from Q1 2026. 4 opened new positions and 0 sold out. The largest holders were Cable Car Capital, LP ($1.5M), Stonepine Capital Management, LLC ($1.1M) and Jupiter Topco LLC ($1.1M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pasithea Therapeutics Corp.
- CUSIP
- 70261F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $1.1M |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 6,751,013 shares bought and 2,782,457 shares sold, net +3,968,556 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Cable Car Capital, LP | 0.03% | Add +148.7% | 3,000,000 | $1.5M |
| Stonepine Capital Management, LLC | 0.86% | Add +164.8% | 2,201,468 | $1.1M |
| Jupiter Topco LLC | 0.00% | — | 2,100,000 | $1.1M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 2,100,000 | $1.1M |
| Opaleye Management Inc. | 0.10% | New | 2,050,000 | $1.1M |
| Ameriprise Financial Inc. | 0.00% | Add +38.0% | 1,864,485 | $961K |
| Squadron Capital Management LLC | 0.18% | Reduce -52.4% | 1,000,000 | $515K |
| AdvisorShares Investments LLC | 0.06% | Add +177.8% | 937,550 | $483K |
| Vivo Capital, LLC | 0.02% | Reduce -77.8% | 465,471 | $240K |
| Persistent Asset Partners Ltd | 0.05% | No change | 290,555 | $150K |
| UBS Group AG | 0.00% | Add +619.4% | 188,111 | $97K |
| XTX Topco Ltd | 0.00% | Add +278.0% | 127,572 | $66K |
| Vanguard Capital Management LLC | 0.00% | Add +134.7% | 126,279 | $65K |
| Geode Capital Management, LLC | 0.00% | Reduce -19.4% | 83,856 | $43K |
| Renaissance Technologies | 0.00% | Reduce -29.8% | 65,600 | $34K |
| Two Sigma Investments, LP | 0.00% | Add +204.8% | 64,166 | $33K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 43,860 | $23K |
| Northern Trust Corp. | 0.00% | Add +62.1% | 31,405 | $16K |
| Jump Financial, LLC | 0.00% | New | 29,363 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +376.7% | 8,838 | $5K |
| Hurley Capital, LLC | 0.00% | Add +89.8% | 7,000 | $4K |
| SBI Securities Co., Ltd. | 0.00% | No change | 1,051 | $542 |
| Barclays PLC | 0.00% | New | 269 | $139 |
| JPMorgan Chase & Co. | 0.00% | No change | 150 | $79 |
| Royal Bank of Canada | 0.00% | New | 275 | $0 |
"% of holder's portfolio" is KTTA's weight in each manager's 13F, not the share of Pasithea Therapeutics Corp. the manager owns.